Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Human immunodeficiency virus (HIV) Clinical Research Samples
Discovery Life Sciences provides the highest quality Human immunodeficiency virus (HIV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Human immunodeficiency virus (HIV) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 334 of 334 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Detail 3 | Product Details | Price | Buy | Blood Type | Consent Status Date | Current Medications | Height | Weight | Menopausal Status | Smoking Notes | Symptoms | HIV IFA | dHIV S/CO | Last Positive HIV Test | Currently Taking ART | Current Drug Therapy | Co-Infections | Current AIDS Related Symptoms | Diagnostic Status | Acquired Infection Category | Current AIDS Symptoms | HIV-1/HIV-2 Antibody Differentiation Immunoassay | Site of Metastasis | History of Benign Disease Prior to Cancer Diagnosis | Clinical Diagnosis | Additional Information | HIV Test Results | Drug Resistance Testing | Abbott Murex HBsAg Version 3 | Abbott Murex Anti-HCV version 4.0 | Co-Infection | Immunoblot | Prism | Elisa | Innolia | DGV | Western Blot INTS | Elisa 2 | Western Blot | Clinical Presentation | Secondary Viral Infection | Previous Exposure History | Additional Testing | Date HIV Positive | ALB | ALK | ALT | AST | BIL | BILD | GGT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACDA000-BY900044471102012DD | Human immunodeficiency virus (HIV) | USA | ACD-A | 1.00 | 1.00 | $75.00 | 34 Y | Male | Non-Hispanic | <-70C | 20-Oct-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $75.00 | Unknown | Positive | 17.79 | ||||||||||||||||||||||||||||||||||||||||||||||
| BBP0000-AB900105690111715DD | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $250.00 | 23 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 23 years 20-Sep-94 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| BBP0000-AB900105691111115DD | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 6 years 7-Jun-09 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| BBP0000-AB900105692111215DD | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $250.00 | 23 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 13-May-13 | Yes | AZT; TDF; 3TC | None | Fever over one month | |||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355232090219DD | Human immunodeficiency virus (HIV) | Serum | 1.40 | 1.00 | $100.00 | Y | Female | Non-Hispanic | <-70C | 02-Sep-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355235090619DD | Human immunodeficiency virus (HIV) | Serum | 1.00 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 06-Sep-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355238042319DD | Human immunodeficiency virus (HIV) | Serum | 1.80 | 1.00 | $100.00 | Y | Female | Hispanic | <-70C | 23-Apr-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355244042319DD | Human immunodeficiency virus (HIV) | Serum | 1.00 | 1.00 | $100.00 | Y | Female | Hispanic | <-70C | 23-Apr-19 | Viral Load | Not Detected | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355246042819DD | Human immunodeficiency virus (HIV) | Serum | 1.20 | 1.00 | $100.00 | Y | Female | Non-Hispanic | <-70C | 28-Apr-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355248100819DD | Human immunodeficiency virus (HIV) | Serum | 1.10 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 08-Oct-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355253040119DD | Human immunodeficiency virus (HIV) | Serum | 1.20 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 01-Apr-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355261050819DD | Human immunodeficiency virus (HIV) | Serum | 1.40 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 08-May-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355270050719DD | Human immunodeficiency virus (HIV) | Serum | 1.70 | 1.00 | $100.00 | Y | Female | Unknown | <-70C | 07-May-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355303040219DD | Human immunodeficiency virus (HIV) | Serum | 2.00 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 02-Apr-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355321100118DD | Human immunodeficiency virus (HIV) | Serum | 1.60 | 1.00 | $100.00 | Y | Female | Hispanic | <-70C | 01-Oct-18 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355330050119DD | Human immunodeficiency virus (HIV) | Serum | 1.80 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 01-May-19 | Viral Load | 365 | HIV | HBSag Result | 348.24 | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355534041419DD | Human immunodeficiency virus (HIV) | Serum | 1.30 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 14-Apr-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355540081919DD | Human immunodeficiency virus (HIV) | Serum | 1.50 | 1.00 | $100.00 | Y | Female | Non-Hispanic | <-70C | 19-Aug-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900355544043019DD | Human immunodeficiency virus (HIV) | Serum | 1.00 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 30-Apr-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900092424081618DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 4.00 | $250.00 | 27 Y | Male | Non-Hispanic | <-70C | 16-Aug-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 1356 cells/uL | 16-Aug-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900092425081418DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $250.00 | 68 Y | Male | Non-Hispanic | <-70C | 14-Aug-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 266 cells/uL | 23-Mar-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | AIDS | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900092430081418DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 4.00 | $250.00 | 65 Y | Male | Non-Hispanic | <-70C | 14-Aug-18 | Roche cobas RT-PCR | 30 copies/mL | HIV | Most Recent CD4 Results | 175 cells/uL | 7-Aug-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | AIDS | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900092435081318DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $250.00 | 49 Y | Male | Non-Hispanic | <-70C | 13-Aug-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 716 cells/uL | 19-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900092436081518DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 6.00 | $250.00 | 44 Y | Male | Non-Hispanic | <-70C | 15-Aug-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 833 cells/uL | 5-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | HIV Seropositive | IV Drug Abuse | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900092439073118DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $250.00 | 58 Y | Male | Non-Hispanic | <-70C | 31-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 320 cells/uL | 16-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096853051718DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $250.00 | 54 Y | Male | Non-Hispanic | <-70C | 17-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 821 cells/uL | 17-May-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096854060618DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $250.00 | 56 Y | Male | Non-Hispanic | <-70C | 06-Jun-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 504 cells/uL | 6-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096855071718DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 17-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 1001 cells/uL | 17-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096856062618DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $250.00 | 44 Y | Male | Non-Hispanic | <-70C | 26-Jun-18 | Roche cobas RT-PCR | 50 copies/mL | HIV | Most Recent CD4 Results | 377 cells/uL | 26-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096857072318DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $250.00 | 61 Y | Male | Non-Hispanic | <-70C | 23-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 1723 cells/uL | 28-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096861060618DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $250.00 | 47 Y | Male | Non-Hispanic | <-70C | 06-Jun-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 1084 cells/uL | 6-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096864062618DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $250.00 | 23 Y | Male | Non-Hispanic | <-70C | 26-Jun-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 592 cells/uL | 26-Jun-18 | HIV Genotype Testing | Genotype B | 20-Oct-17 | $250.00 | Unknown | None | U/A | AIDS | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096866062718DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $250.00 | 55 Y | Female | Non-Hispanic | <-70C | 27-Jun-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 731 cells/uL | 6-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096868051518DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $250.00 | 32 Y | Male | Non-Hispanic | <-70C | 15-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 961 cells/uL | 18-Apr-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096869072318DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 5.00 | $250.00 | 29 Y | Male | Non-Hispanic | <-70C | 23-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 488 cells/uL | 23-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | Syphilis | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900096870073018DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $250.00 | 52 Y | Male | Non-Hispanic | <-70C | 30-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 930 cells/uL | 23-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900097162061818DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $250.00 | 39 Y | Male | Non-Hispanic | <-70C | 18-Jun-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 270 cells/uL | 18-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900097659080118DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $250.00 | 57 Y | Male | Non-Hispanic | <-70C | 01-Aug-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 26 cells/uL | 1-Aug-18 | HIV Genotype Testing | Genotype B | 21-Nov-17 | $250.00 | Unknown | None | None | AIDS | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900107807051618DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $250.00 | 23 Y | Male | Non-Hispanic | <-70C | 16-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 846 cells/uL | 16-May-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900109186052218DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $250.00 | 53 Y | Female | Non-Hispanic | <-70C | 22-May-18 | Roche cobas RT-PCR | 140 copies/mL | HIV | Most Recent CD4 Results | 476 cells/uL | 22-May-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900109581081318DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $250.00 | 43 Y | Male | Non-Hispanic | <-70C | 13-Aug-18 | Roche cobas RT-PCR | 20 copies/mL | HIV | Most Recent CD4 Results | 1266 cells/uL | 6-Aug-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | None | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900109591073118DD | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 6.00 | $250.00 | 26 Y | Male | Non-Hispanic | <-70C | 31-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 488 cells/uL | 29-May-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900355600120919DD | Human immunodeficiency virus (HIV) | Serum | 2.50 | 2.00 | $110.00 | Y | Male | Non-Hispanic | <-70C | 09-Dec-19 | Roche cobas Taqman | RT-PCR | 20.00 | 2019-11-05 | Most Recent CD4 Results | 582 cells/uL | 5-Nov-19 | $110.00 | Unknown | 2019-12-09 | Yes Genvoya started on 5-Jun-2017 | HIV Seropositive | Sexual Transmission | Syphilis | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-BD900355601120919DD | Human immunodeficiency virus (HIV) | Serum | 4.00 | 2.00 | $110.00 | Y | Male | Non-Hispanic | <-70C | 09-Dec-19 | Roche cobas Taqman | RT-PCR | 11890.00 | 2019-10-28 | Most Recent CD4 Results | 509 cells/uL | 28-Oct-19 | $110.00 | Unknown | 2019-12-09 | Yes Descovy, Evotaz started 17-Apr-2017 | HIV Seropositive | Sexual Transmission | None | HIV-1 Positive 21-Dec-17 | |||||||||||||||||||||||||||||||||||||||||||
| BBS0000-CV900098576100416DD | Human immunodeficiency virus (HIV) | Vietnam | Serum | 1.00 | 9.00 | $250.00 | 43 Y | Male | Non-Hispanic | <-70C | 04-Oct-16 | Staging | Tumor N/A; N1 | $250.00 | Unknown | Unknown | Former 20 per day for 10 years | Lymph Nodes | No | Metastatic Carcinoma; HIV | Neck lymph node biopsy: The structure replaced by tumor tissue structures with large nuclear tumor cells, clear nuclear alkaline. Immunohistochemistry staining: tumor cells (+) to marker CK17, negative with remaining markers: CK20, P63, TTTF1, LCA, Napsin, CDX2, S100, HMB45. Conclusion: Gland carcinoma lymph node metastasis. | ||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028134070218DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $250.00 | 36 Y | Female | Non-Hispanic | <-70C | 02-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 928 cells/uL | 2-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | AIDS | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028135051418DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $250.00 | 57 Y | Female | Non-Hispanic | <-70C | 14-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 637 cells/uL | 14-May-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028136053118DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $250.00 | 56 Y | Female | Non-Hispanic | <-70C | 31-May-18 | Roche cobas RT-PCR | 19300 copies/mL | HIV | Most Recent CD4 Results | 523 cells/uL | 31-May-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028137051418DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $250.00 | 49 Y | Male | Non-Hispanic | <-70C | 14-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 454 cells/uL | 13-Apr-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028138052218DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $250.00 | 48 Y | Female | Non-Hispanic | <-70C | 22-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 925 cells/uL | 22-May-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028139051518DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $250.00 | 53 Y | Male | Non-Hispanic | <-70C | 15-May-18 | Roche cobas RT-PCR | 60 copies/mL | HIV | Most Recent CD4 Results | 399 cells/uL | 13-Mar-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028140053118DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $250.00 | 39 Y | Female | Non-Hispanic | <-70C | 31-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 1113 cells/uL | 31-May-18 | HIV Genotype Testing | Genotype B | 31-May-16 | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028142053118DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $250.00 | 45 Y | Male | Non-Hispanic | <-70C | 31-May-18 | Roche cobas RT-PCR | 60 copies/mL | HIV | Most Recent CD4 Results | 769 cells/uL | 31-May-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900028143051018DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $250.00 | 38 Y | Female | Non-Hispanic | <-70C | 10-May-18 | Roche cobas RT-PCR | 1,420 copies/mL | HIV | Most Recent CD4 Results | 477 cells/uL | 5-Apr-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900033071073018DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $250.00 | 50 Y | Female | Non-Hispanic | <-70C | 30-Jul-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 922 cells/uL | 30-Jul-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900033073051518DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $250.00 | 59 Y | Male | Non-Hispanic | <-70C | 15-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 456 cells/uL | 15-May-18 | HIV Genotype Testing | N/A | $250.00 | Unknown | None | U/A | HIV Seropositive | IV Drug Abuse | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900033074060518DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 55 Y | Male | Non-Hispanic | <-70C | 05-Jun-18 | Roche cobas RT-PCR | 21660 copies/mL | HIV | Most Recent CD4 Results | 217 cells/uL | 5-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | AIDS | IV Drug Abuse | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900033076052218DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $250.00 | 37 Y | Male | Non-Hispanic | <-70C | 22-May-18 | Roche cobas RT-PCR | <20 copies/mL | HIV | Most Recent CD4 Results | 488 cells/uL | 22-May-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900033081060618DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $250.00 | 37 Y | Male | Non-Hispanic | <-70C | 06-Jun-18 | Roche cobas RT-PCR | 32070 copies/mL | HIV | Most Recent CD4 Results | 493 cells/uL | 6-Jun-18 | HIV Genotype Testing | Genotype B | 10-Aug-16 | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-BD900033083062818DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 34 Y | Male | Non-Hispanic | <-70C | 28-Jun-18 | Roche cobas RT-PCR | 160 copies/mL | HIV | Most Recent CD4 Results | 746 cells/uL | 27-Jun-18 | HIV Genotype Testing | U/A | $250.00 | Unknown | None | U/A | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900081507021414DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 28 Y | Male | Non-Hispanic | <-70C | 14-Feb-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 829 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900081509060314DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 22 Y | Male | Non-Hispanic | <-70C | 03-Jun-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 819 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900081510062514DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 31 Y | Male | Hispanic | <-70C | 25-Jun-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 642 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900081511082713DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 51 Y | Male | Non-Hispanic | <-70C | 27-Aug-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 814 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900081512091313DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 33 Y | Male | Non-Hispanic | <-70C | 13-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 483 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084638091313DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 27 Y | Male | Unknown | <-70C | 13-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 584 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084639091813DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 44 Y | Male | Non-Hispanic | <-70C | 18-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 703 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084640092513DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $100.00 | 46 Y | Male | Unknown | <-70C | 25-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 800 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084648092613DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 50 Y | Male | Non-Hispanic | <-70C | 26-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 455 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084649100113DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $100.00 | 48 Y | Male | Non-Hispanic | <-70C | 01-Oct-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 1,239 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084652110713DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 48 Y | Male | Non-Hispanic | <-70C | 07-Nov-13 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 1084 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084653071513DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $100.00 | 41 Y | Male | Non-Hispanic | <-70C | 15-Jul-13 | Abbott RealTime HIV-1 Viral Load | 69 copies/mL | HIV | CD4 Result | 1,357 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084654120514DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $100.00 | 37 Y | Male | Unknown | <-70C | 05-Dec-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 556 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084655121914DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 29 Y | Male | Non-Hispanic | <-70C | 19-Dec-14 | Bayer HIV-1 RNA Assay V 3.0 | 40 copies/mL | HIV | CD4 Result | 662 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BK900084656011515DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $100.00 | 66 Y | Male | Non-Hispanic | <-70C | 15-Jan-15 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 477 U/L | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900036026122214DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $250.00 | 31 Y | Female | Non-Hispanic | < -70C | 22-Dec-14 | Siemens Trugene | No resistance | 12-Apr-11 | Beckman Coulter CD4 Result | 361 | 17-Dec-14 | Roche Amplicor RT-PCR | 678 cps/mL | 17-Dec-14 | $250.00 | Unknown | Yes; Darunavir, Ritonavir, Truvada | N/A | HIV Seropositive | Sexual Transmission | No | Last Positive Test Jun-2009 Test - Unknown Subject seropositive 5 years (per MD note) | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900036027120914DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $250.00 | 45 Y | Male | Non-Hispanic | < -70C | 09-Dec-14 | Siemens Trugene | RT-T69N | 27-May-14 | Beckman Coulter CD4 Result | 22 | 25-Nov-14 | Roche Amplicor RT-PCR | 26,014 cps/mL | 25-Nov-14 | $250.00 | Unknown | Yes; Atazanavir, Stribild | N/A | HIV Seropositive | Sexual Transmission | No | Last Positive Test 1990 Test - Unknown Subject seropositive 24 years (per patient) | PhenoSense Integrase Result: Sensitive to All 27-May-2014 | |||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900036028020615DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 36 Y | Female | Non-Hispanic | <-70C | 06-Feb-15 | Roche Amplicor | 2,919 copies/mL | 29-Jan-15 | Most Recent CD4 Results | 215 cells/uL | 23-Jan-15 | Siemens Trugene | PR-K20R | 29-Jan-15 | $250.00 | Unknown | Yes | Atripla | Hepatitis C | No | HIV Seropositive | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900036029022315DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $250.00 | 48 Y | Female | Non-Hispanic | <-70C | 23-Feb-15 | Siemens Trugene | PR-M36I | 11-Apr-13 | CD4 result | 125 cells/uL | Most Recent Viral Load (Roche Amplicor) | 386 copies/mL | 15-Dec-14 | $250.00 | Unknown | Seropositive for 11 years 2-Jun-14 | Yes Truvada; Norvir; Reyataz | Hepatitis A, B and C; HCV 1b; VL 1,918,225 | HIV Seropositive AIDS | U/A | Diarrhea; Fatigue | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900036030120914DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 52 Y | Male | Non-Hispanic | < -70C | 09-Dec-14 | Siemens Trugene | N/A | Beckman Coulter CD4 Result | 43 | 21-Nov-14 | Roche Amplicor RT-PCR | 104,351 cps/mL | 21-Nov-14 | $250.00 | Unknown | Yes; Atazanavir, Truvada, Ritonavir | Chronic Hepatitis C | AIDS | Sexual Transmission | Secretory diarrhea | Last Positive Test 1999 Test - Unknown Subject seropositive 15 years (per patient) | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900036031022315DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 59 Y | Male | Non-Hispanic | <-70C | 23-Feb-15 | Siemens Trugene | PR-A71T | 18-Aug-14 | CD4 result | 151 cells/uL | Most Recent Viral Load (Roche Amplicor) | 591 copies/mL | 26-Jan-15 | $250.00 | Unknown | Seropositive for 2 years 20-Mar-13 | Yes Stribild | Toxoplasma gondii IgG - 1.7 | HIV Seropositive AIDS | U/A | No | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900036032020615DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $250.00 | 54 Y | Female | Non-Hispanic | < -70C | 06-Feb-15 | Siemens Trugene | RT-D67N, T69D, K101E, H208Y, K219Q | 27-Oct-14 | Beckman Coulter CD4 Result | 80 | 17-Dec-14 | Most Recent Viral Load (Roche Amplicor) | 62,090 copies/mL | 17-Dec-14 | $250.00 | Unknown | 4-May Test - Unknown; Subject seropositive 11 years (MD notes) | Yes; Raltegravir, Ritonavir, Rilpivirine | HCV +; HPV +; HAV total Ab + 2014; 2010; 2014 | HIV Seropositive | Sexual Transmission | No | PhenoSense Integrase; Result: Sensitive to All 27-Oct-14 | |||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041711120814DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 56 Y | Female | Non-Hispanic | < -70C | 08-Dec-14 | Siemens Trugene | RT-L100I, V179D, M184V PR-A71T | 8-Jan-14 | Beckman Coulter CD4 Result | 153 | 15-Oct-14 | Roche Amplicor RT-PCR | 5,187 cps/mL | 15-Oct-14 | $250.00 | Unknown | Yes; Darunavir, Truvada, Ritonavir | Hepatitis B | HIV Seropositive | Sexual Transmission | Shingles 26-Nov-2014 | Last Positive Test 20-Aug-2008 Test - Oraquick Subject seropositive 6 years | PhenoSense Integrase Result: Sensitive to Dolutegravir, Elvitegravir, Raltegravir | |||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041712020515DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $250.00 | 52 Y | Female | Non-Hispanic | < -70C | 05-Feb-15 | Siemens Trugene | PR-K20R, M36I | 27-Feb-14 | Beckman Coulter CD4 Result | 32 | 27-Feb-14 | Most Recent Viral Load (Roche Amplicor) | 90,268 copies/mL | 27-Feb-14 | $250.00 | Unknown | 1988 Test - Unknown; Subject seropositive 27 years (MD notes) | Yes; Darunavir, Tenofovir, Ritonavir, Zidovudine | N/A | HIV Seropositive; AIDS | Sexual Transmission | No | N/A | |||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041713120814DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 46 Y | Female | Non-Hispanic | < -70C | 08-Dec-14 | Siemens Trugene | No resistance | 4-Aug-14 | Beckman Coulter CD4 Result | 256 | 4-Aug-14 | Roche Amplicor RT-PCR | 28,108 cps/mL | 4-Aug-14 | $250.00 | Unknown | No | N/A | HIV Seropositive | Sexual Transmission | Lymphadenopathy 4-Aug-2014 Microcytic anemia 04-Dec-2014 | Last Positive Test 22-Jun-2008 Test - Western Blot Subject seropositive 6 years | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041714020515DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $250.00 | 40 Y | Male | Non-Hispanic | < -70C | 05-Feb-15 | Siemens Trugene | RT-M41L, K103N | 9-Jan-14 | Beckman Coulter CD4 Result | 24 | 13-Nov-14 | Most Recent Viral Load (Roche Amplicor) | 118,544 copies/mL | 13-Nov-14 | $250.00 | Unknown | 6-Aug-08 Test - Unknown; Subject seropositive 7 years (MD notes) | Yes; Atazanavir, Truvada | Syphilis + 2014 | HIV Seropositive; AIDS | Unknown | Yes; Nausea | N/A | |||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041715020515DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $250.00 | 38 Y | Male | Non-Hispanic | < -70C | 05-Feb-15 | Siemens Trugene | RT-V106I, PR-M36I | 22-Jan-13 | Beckman Coulter CD4 Result | 106 | 14-Jan-15 | Most Recent Viral Load (Roche Amplicor) | 34,500 copies/mL | 14-Jan-15 | $250.00 | Unknown | 21-Jan-13 Test -Oraquick; Subject seropositive 2 years | Yes; Truvada, Ritonavir | Hep A +; Syphilis; Disseminated Pulmonary MAC 2015; 2013; 2013 | HIV Seropositive; AIDS | Sexual Transmission | Yes; Abnormal U/A | N/A | |||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041716120914DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 33 Y | Female | Non-Hispanic | < -70C | 09-Dec-14 | Siemens Trugene | RT-K103N, P225H | 3-Dec-12 | Beckman Coulter CD4 Result | 276 | 16-Oct-14 | Roche Amplicor RT-PCR | 5,005 cps/mL | 16-Oct-14 | $250.00 | Unknown | Yes; Truvada, Raltegravir | N/A | HIV Seropositive | Sexual Transmission | No | Last Positive Test 2005 Test - Unknown Subject seropositive 9 years (per patient) | PhenoSense Integrase Result: Sensitive to Raltegravir and Elvitegravir | |||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041717020215DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $250.00 | 60 Y | Male | Non-Hispanic | < -70C | 02-Feb-15 | Siemens Trugene | PR-L10V, K20T, A71I, L90M, RT-M41L, M184V, H208Y, L210W, T215Y | 22-Oct-13 | Beckman Coulter CD4 Result | 85 | 16-Dec-13 | Most Recent Viral Load (Roche Amplicor) | 92,979 copies/mL | 16-Dec-13 | $250.00 | Unknown | 21-Jan-03 Test - Unknown; Subject seropositive 12 years | Yes; Darunavir, Etravirine, Maraviroc, Ritonavir | N/A | HIV Seropositive; AIDS | Sexual Transmission | Yes; Diarrhea | PhenoSense Integrase; Result: Sensitive to All 22-Oct-13 | |||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900041727121614DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $250.00 | 47 Y | Female | Non-Hispanic | < -70C | 16-Dec-14 | Siemens Trugene | RT-T215C, PR-A71T, L90M | 11-May-11 | Beckman Coulter CD4 Result | 357 | 7-Nov-14 | Roche Amplicor RT-PCR | 7,854 cps/mL | 7-Nov-14 | $250.00 | Unknown | No | N/A | HIV Seropositive | Sexual Transmission | No | Last Positive Test 1996 Test - Unknown Subject seropositive 18 years (per MD note) | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900047479022315DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 51 Y | Male | Non-Hispanic | <-70C | 23-Feb-15 | Siemens Trugene | RT-D67N, K70R, V90I, K103N, V108I, M184V, K219E, P225H | 3-Mar-11 | CD4 result | 538 cells/uL | Most Recent Viral Load (Roche Amplicor) | 204 copies/mL | 25-Nov-14 | $250.00 | Unknown | Seropositive for 14 years 6-Apr | Yes Stribild | HCV 1a; VL 22,663,488; HAV + | HIV Seropositive | Transfusion | Neuropathy - HIV vs DM | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900047480031215DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $250.00 | 40 Y | Male | Non-Hispanic | <-70C | 12-Mar-15 | Siemens Trugene | RT-K103N, M41L | 9-Jan-14 | CD4 result | 48 cells/uL | Most Recent Viral Load (Roche Amplicor) | 116,613 copies/mL | 5-Feb-15 | $250.00 | Unknown | Seropositive for 7 years 6-Aug-08 | Yes Atazanavir; Truvada; Norvir | STI - Trep. Pall > 8.0 + | HIV Seropositive AIDS | Sexual Transmission | No | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900066357122214DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $250.00 | 41 Y | Female | Non-Hispanic | < -70C | 22-Dec-14 | Siemens Trugene | No resistance | 23-Jul-14 | Beckman Coulter CD4 Result | 4 | 17-Dec-14 | Roche Amplicor RT-PCR | 14,984 cps/mL | 17-Dec-14 | $250.00 | Unknown | Yes; Darunavir, Dolutegravir, Truvada | N/A | HIV Seropositive | Sexual Transmission | Diarrhea (Esophageal candida on 3-Sep-2014 and 16-Oct-2014) | Last Positive Test Oct-2003 Test - Unknown Subject seropositive 13-years | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-BW900066358121514DD | Human immunodeficiency virus (HIV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $250.00 | 49 Y | Male | Non-Hispanic | < -70C | 15-Dec-14 | Siemens Trugene | No mutations | 6-Aug-14 | Beckman Coulter CD4 Result | 72 | 22-Jan-14 | Roche Amplicor RT-PCR | 34,817 cps/mL | 6-Aug-14 | $250.00 | Unknown | No | Hepatitis C 30-Oct-2013 Stable | HIV Seropositive | IV Drug Abuse | No | Last Positive Test 20-Sep-2011 Test - Unknown Subject seropositive 3 years (from prison record) (patient says since 2002) | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108102110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 1.00 | $50.00 | 19 Y | Female | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | 6,320 copies/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108103110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 2.00 | $50.00 | 42 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | 5,970 copies/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108105110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 3.00 | $50.00 | 28 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | 307 cps/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108227110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 3.00 | $50.00 | 25 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | <40 cps/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108228110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 2.00 | $50.00 | 24 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | <40 cps/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-AB900108229110119DD | Human immunodeficiency virus (HIV) | Uganda | Citrated Plasma | 1.00 | 4.00 | $50.00 | 19 Y | Male | Non-Hispanic | < -70C | 02-Nov-19 | Roche cobas | <40 cps/mL | HIV | EuroGentec S.A. HIV Genotype | D | $50.00 | Unknown | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036057102209DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 31 Y | Male | Unknown | <-70°C | 22-Oct-09 | Abbott Prism | 86 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036058051410DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 28 Y | Female | Unknown | <-70°C | 14-May-10 | Abbott Prism | 140 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036059063010DD | Human immunodeficiency virus (HIV) | Germany | Citrated Plasma | 1.00 | 1.00 | $50.00 | 61 Y | Male | Unknown | <-70°C | 30-Jun-10 | Abbott Prism | 162 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(2+) | $50.00 | Unknown | Syphilis | ||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036060081710DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 32 Y | Male | Unknown | <-70°C | 17-Aug-10 | Abbott Prism | 136 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036061090810DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 40 Y | Male | Unknown | <-70°C | 08-Sep-10 | Abbott Prism | 162 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036062090810DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 34 Y | Male | Unknown | <-70°C | 08-Sep-10 | Abbott Prism | 82 S/Co | HIV | Immunoblot | gp120(+/-) gp41(2+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036063090810DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 22 Y | Male | Unknown | <-70°C | 08-Sep-10 | Abbott Prism | 153 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036065120710DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 21 Y | Male | Unknown | <-70°C | 07-Dec-10 | Abbott Prism | 104 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036066121110DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 46 Y | Male | Unknown | <-70°C | 11-Dec-10 | Abbott Prism | 128 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036067012611DD | Human immunodeficiency virus (HIV) | Italy | Citrated Plasma | 1.00 | 2.00 | $50.00 | 29 Y | Male | Unknown | <-70°C | 26-Jan-11 | Abbott Prism | 94 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036068020311DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 23 Y | Male | Unknown | <-70°C | 03-Feb-11 | Abbott Prism | 70 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900036070032511DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 48 Y | Male | Unknown | <-70°C | 25-Mar-11 | Abbott Prism | 153 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060022072111DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 24 Y | Female | Unknown | <-70°C | 21-Jul-11 | Abbott Prism | 126 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060023092711DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 27 Y | Male | Unknown | <-70°C | 27-Sep-11 | Abbott Prism | 9.58 S/Co | HIV | Immunoblot | gp120(-) gp41(2+) 2ENV(-) p31(-) p24(+/-) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060024110911DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 36 Y | Male | Unknown | <-70°C | 09-Nov-11 | Abbott Prism | 150 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060025120511DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 26 Y | Male | Unknown | <-70°C | 05-Dec-11 | Abbott Prism | 96 S/Co | Co-Infection | Syphilis | $50.00 | Unknown | gp120(4+) gp41(4+) 2ENV(-) p31(3+) p24(4+) | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060026011312DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 45 Y | Male | Unknown | <-70°C | 13-Jan-12 | Abbott Prism | 111 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060027012812DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 42 Y | Male | Unknown | <-70°C | 28-Jan-12 | Abbott Prism | 98 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060028013112DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 31 Y | Male | Unknown | <-70°C | 31-Jan-12 | Abbott Prism | 49 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(3+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900060029022312DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 50 Y | Female | Unknown | <-70°C | 23-Feb-12 | Abbott Prism | 90 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066322022512DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 26 Y | Male | Unknown | <-70°C | 25-Feb-12 | Abbott Prism | 92 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(+/-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066323022912DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 42 Y | Male | Unknown | <-70°C | 29-Feb-12 | Abbott Prism | 86 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(-) p24(2+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066324030212DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 26 Y | Male | Unknown | <-70°C | 02-Mar-12 | Abbott Prism | 84 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(3+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066325040412DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 38 Y | Male | Unknown | <-70°C | 04-Apr-12 | Abbott Prism | 116 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066326051012DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 27 Y | Male | Unknown | <-70°C | 10-May-12 | Abbott Prism | 84 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066327050712DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 24 Y | Female | Unknown | <-70°C | 07-May-12 | Abbott Prism | 121 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(+/-) p31(2+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066328053112DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 27 Y | Male | Unknown | <-70°C | 31-May-12 | Abbott Prism | 131 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(2+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066329060712DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 35 Y | Female | Unknown | <-70°C | 07-Jun-12 | Abbott Prism | 119 S/Co | HIV | Immunoblot | Gp120(3+) gp41(4+) 2ENV(-) p31(3+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066330070912DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 36 Y | Male | Unknown | <-70°C | 09-Jul-12 | Abbott Prism | 136 S/Co | HIV | Immunoblot | sgp120(3+) gp41(3+) p31(2+) p24(3+) p17(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066331111012DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 19 Y | Male | Unknown | <-70°C | 10-Nov-12 | Abbott Prism | 146.5 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) p31(3+) p24(2+) p17(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066332112012DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $50.00 | 36 Y | Male | Unknown | <-70°C | 20-Nov-12 | Abbott Prism | 80.37 S/Co | HIV | Immunoblot | sgp120(2+) gp41(3+) p31(2+) p24(2+) p17(2+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066396051107DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 34 Y | Male | Unknown | <-70°C | 11-May-07 | Abbott Prism | 16.88 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(+/-) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066397051807DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 44 Y | Male | Unknown | <-70°C | 18-May-07 | Abbott Prism | 15.33 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066399032305DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 40 Y | Male | Unknown | <-70°C | 23-Mar-05 | Abbott Prism | 123.23 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066400041107DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 25 Y | Male | Unknown | <-70°C | 11-Apr-07 | Abbott Prism | 108.89 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066401121107DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 39 Y | Male | Unknown | <-70°C | 11-Dec-07 | Abbott Prism | 132 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066402010808DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 54 Y | Female | Unknown | <-70°C | 08-Jan-08 | Abbott Prism | 72.79 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(2+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066404022208DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 27 Y | Male | Unknown | <-70°C | 22-Feb-08 | Abbott Prism | 99.31 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107002053011DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $50.00 | 26 Y | Male | Unknown | <-70°C | 30-May-11 | Abbott Prism | 72 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(+/-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107004060311DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 34 Y | Female | Unknown | <-70°C | 03-Jun-11 | Abbott Prism | 72 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(+/-) p31(4+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107005061811DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 35 Y | Male | Unknown | <-70°C | 18-Jun-11 | Abbott Prism | 7.55 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(2+) p24(4+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900107017051911DD | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $50.00 | 19 Y | Male | Unknown | <-70°C | 19-May-11 | Abbott Prism | 114 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(2+) | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900085321090111DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 3.00 | $50.00 | Unknown | < -70C | 01-Sep-11 | Roche cobas | 964 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 149.48 | 12.605 | Positive | Pos | p18 (2+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | |||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900085322012411DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $50.00 | Unknown | < -70C | 24-Jan-11 | Roche cobas | 444 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 11.811 | Positive | Pos | p18 (2+); p24 (3+); p34 (3+); gp41 (3+); p55 (2+); p68 (3+); gp120 (3+); gp160 (3+) | 13.246 | |||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900085323032811DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $50.00 | Unknown | < -70C | 28-Mar-11 | Roche cobas | 416 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 11.45 | Positive | Pos | p18 (+/-); p24 (1+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | 14.907 | |||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900086483052710DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $50.00 | Unknown | < -70C | 27-May-10 | Roche cobas | 7,621 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 118.6 | 11.167 | Positive sgp41(4+); gp120 (2+); p31 (2+); p24 (2+); p17 (2+); sgp105 (--); gp36 (--) | Pos | ||||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900108431071710DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $50.00 | Unknown | < -70C | 17-Jul-10 | Roche cobas | 2,525 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 10.83 | Positive | Pos | 16.043 | p18 (3+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) AgP24 Négatif | |||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900108434101810DD | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $50.00 | Unknown | < -70C | 18-Oct-10 | Roche cobas | 1,152 copies/mL | HIV | Genotype: | B | Serotype: B | $50.00 | Unknown | 10.563 | Positive | Pos | 14.282 | p18 (2+); p24 (3+); p34 (3+); gp41 (2+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) AgP24 Négatif | |||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900038160053012DD | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 1.00 | $100.00 | 23 Y | Male | Hispanic | <-70C | 30-May-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 21.83 | ||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900038162013114DD | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 1.00 | $100.00 | 30 Y | Female | Non-Hispanic | <-70C | 31-Jan-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 78.9 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 86.83 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 85.43 | $100.00 | Unknown | Not Tested | 21.36 | ||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900038163042413DD | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 1.00 | $100.00 | 19 Y | Male | Non-Hispanic | <-70C | 24-Apr-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 27.97 | ||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044470061114DD | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 1.00 | $100.00 | 21 Y | Male | Hispanic | <-70C | 11-Jun-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 135.63 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 112.69 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 107.99 | $100.00 | Unknown | Not Tested | 21.17 | ||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044472040412DD | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 1.00 | $100.00 | 34 Y | Male | Non-Hispanic | <-70C | 04-Apr-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 9.623 | $100.00 | Unknown | Positive | 28.26 | ||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044473030412DD | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 1.00 | $100.00 | 54 Y | Female | Hispanic | <-70C | 04-Mar-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 29.91 | ||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044474032613DD | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 1.00 | $100.00 | 51 Y | Female | Non-Hispanic | <-70C | 26-Mar-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 27.29 | ||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044476041213DD | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 2.00 | $100.00 | 49 Y | Male | Non-Hispanic | <-70C | 12-Apr-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | 0.62 (NR) | ||||||||||||||||||||||||||||||||||||||||||||||
| CP20000-BY900044477072614DD | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 2.00 | $100.00 | 40 Y | Male | Unknown | <-70C | 26-Jul-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 123.82 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 131.55 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 125.95 | $100.00 | Unknown | Not Tested | 22.98 | ||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032290111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 17-Oct-15 | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032826111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 23 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 11-May-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032828111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 28 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 7-May-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032829111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 8 years 10-Jun-07 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032830111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 33 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 10-Nov-15 | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032831111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 23 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 14-Mar-15 | Yes | AZT; TDF; 3TC | Cough | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032832111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 37 Y | Male | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 17-Nov-15 | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032833111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 28 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 11-Sep-13 | Yes | AZT; TDF; 3TC | Malaria | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900032834111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 35 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 3 years 20-Aug-12 | Yes | AZT; TDF; 3TC | Skin Rash | Disseminated skin rash | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036805111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 20 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 10-Jul-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036806111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 25 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 20-Jul-14 | Yes | AZT; TDF; 3TC | Diarrhea | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036807111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 42 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 15 years 13-Jul-00 | Yes | AZT; TDF; 3TC | Diarrhea | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036808111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 45 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 10-Jul-15 | Yes | AZT; TDF; 3TC | Tuberculosis | Unexplained loss of weight over 10% | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036809111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 24 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 17-Aug-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036810111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 20 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 16-Sep-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036811111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 20-Dec-13 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036812111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 36 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 12-Jan-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036813111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 34 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 4-Jun-13 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900036814111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 18 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 12-Nov-15 | No | Panadol; Amoxyl | Skin Rash | Herpes Simplex | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042615111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 14-Aug-15 | Yes | AZT; TDF; 3TC | Malaria | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042616111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 10-Nov-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042619111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 33 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 12-Nov-15 | No | Coartem; Panadol | Respiratory Tract Infection | Unexplained loss of weight and fever for over 1 month | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042620111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 38 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 10-Jun-13 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042621111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 4-Jul-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042622111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 22 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 11-Nov-15 | No | None | Tuberculosis | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042623111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 20-Apr-15 | Yes | Septrin; AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042624111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 4.00 | $250.00 | 42 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 6 years 4-Jun-09 | Yes | AZT; TDF; 3TC | Malaria | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042625111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 22 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 10-Oct-15 | Yes | Septrin; Amoxyl; AZT; TDF; 3TC | Cough | Herpes Zoster | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900042626111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 27 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 14-Apr-13 | Yes | AZT; TDF; 3TC | Skin Rash | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046324111015DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 30 Y | Female | Non-Hispanic | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 10-Apr-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046327111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 24 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 14-Aug-13 | Yes | AZT; TDF; 3TC | Cough | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046328111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 22 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 20-Feb-13 | Yes | AZT; TDF; 3TC | Skin Rash | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046334111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 28 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 11-Nov-15 | No | None | Skin Rash | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046335111715DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 38 Y | Female | Non-Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 2 years 10-Feb-13 | Yes | AZT; TDF; 3TC | Skin Rash | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046336111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 35 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 12-Jun-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046337111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 27 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 11-Jul-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900046338111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 25 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 21-Apr-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079015111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 31 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 3 years 20-Aug-12 | Yes | AZT; TDF; 3TC | Cough | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079016111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 2.00 | $250.00 | 21 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive New Case 16-Nov-15 | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079017111615DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 19 Y | Female | Non-Hispanic | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 20-Jul-15 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079018111115DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 26 Y | Female | Non-Hispanic | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 2-Mar-14 | Yes | AZT; TDF; 3TC | None | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079019111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 3.00 | $250.00 | 30 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive 1 year 2-Jan-14 | Yes | AZT; TDF; 3TC | Respiratory Tract Infection | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AB900079020111215DD | Human immunodeficiency virus (HIV) | Uganda | Double Spun Plasma | 1.00 | 1.00 | $250.00 | 25 Y | Female | Non-Hispanic | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | STAT-PACK; Seropositive < 1 year 4-Jun-15 | Yes | AZT; TDF; 3TC | Malaria | No | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AC900080479110119DD | Human immunodeficiency virus (HIV) | Double Spun Plasma | 1.00 | 6.00 | $250.00 | 27 Y | Female | Hispanic | < -70C | 01-Nov-19 | Roche Amplicor | 8,530 copies/mL | HIV | $250.00 | Unknown | Efavirenz, Truvada, Omeprazole | 62.99 | 94 | None | Cervical Dysplasia | HPV | Sexual Contact | |||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AC900080480110119DD | Human immunodeficiency virus (HIV) | Double Spun Plasma | 1.00 | 8.00 | $250.00 | 23 Y | Female | Hispanic | < -70C | 01-Nov-19 | Roche Amplicor | <40 copies/mL | HIV | $250.00 | Unknown | INH (Isoniazid) 300 mg/day | 66.54 | 152 | Asymptomatic | Asymptomatic; CD4 count - 540 | Genital HPV | Sexual Contact | |||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AC900080481110119DD | Human immunodeficiency virus (HIV) | Double Spun Plasma | 1.00 | 7.00 | $250.00 | 37 Y | Male | Hispanic | < -70C | 01-Nov-19 | Viral Load | Not Detected | HIV | $250.00 | Unknown | INH (Isoniazid), Rifampin, Ethambutol, PZA | 66.93 | 147 | Intestinal HPV, Oral Candida, Genital Worts | Intestinal TB | HPV | Sexual Contact | |||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039983012710DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 43 Y | Male | Non-Hispanic | <-70C | 27-Jan-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 753 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039984020910DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 44 Y | Male | Non-Hispanic | <-70C | 09-Feb-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 550 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039985030810DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 41 Y | Male | Non-Hispanic | <-70C | 08-Mar-10 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 529 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039986031010DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 45 Y | Male | Unknown | <-70C | 10-Mar-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 2083 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039987042010DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 56 Y | Male | Non-Hispanic | <-70C | 20-Apr-10 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 504 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039988060810DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 41 Y | Male | Non-Hispanic | <-70C | 08-Jun-10 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 520 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039989112910DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 42 Y | Male | Non-Hispanic | <-70C | 29-Nov-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 735 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039990021111DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 43 Y | Male | Non-Hispanic | <-70C | 11-Feb-11 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 658 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039991041411DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.25 | 2.00 | $100.00 | 46 Y | Male | Non-Hispanic | <-70C | 14-Apr-11 | Chiron 1st Generation | 40 copies/mL | HIV | CD4 Result | 729 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039992041411DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 4.00 | $50.00 | 64 Y | Male | Non-Hispanic | <-70C | 14-Apr-11 | Roche Ultrasensitive | HIV | CD4 Result | 498 cells/uL | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900039993060911DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 4.00 | $50.00 | 59 Y | Male | Non-Hispanic | <-70C | 09-Jun-11 | Chiron 3.0 | HIV | CD4 Result | 390 cells/uL | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900084658010510DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 54 Y | Male | Non-Hispanic | <-70C | 05-Jan-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 702 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900084659011910DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 3.00 | $100.00 | 59 Y | Female | Non-Hispanic | <-70C | 19-Jan-10 | Roche Ultrasensitive | 257 copies/mL | HIV | CD4 Result | 672 cells/uL | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BK900084660012010DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 4.00 | $50.00 | 50 Y | Male | Non-Hispanic | <-70C | 20-Jan-10 | Chiron 3.0 | HIV | CD4 Result | 683 cells/uL | $50.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BY900038161080112DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 1.00 | $100.00 | 22 Y | Male | Unknown | <-70C | 01-Aug-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $100.00 | Unknown | Positive | NAT R but QNS for discrim testing | ||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BY900044459050812DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 1.00 | $50.00 | 19 Y | Male | Non-Hispanic | <-70C | 08-May-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 9.939 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | >10.000 | $50.00 | Unknown | Positive | 23.63 | |||||||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BY900044475060313DD | Human immunodeficiency virus (HIV) | USA | Double Spun Plasma | 1.00 | 1.00 | $50.00 | 21 Y | Male | Non-Hispanic | <-70C | 03-Jun-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | >10.000 | $50.00 | Unknown | Positive | 32.1 | |||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900047254020117DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 13 Y | Female | Non-Hispanic | <-70C | 01-Feb-17 | Abbott M2000 RT-PCR | Not Detected | 1-Feb-17 | Most Recent CD4 Results | 998 cells/uL | 10-Jan-17 | 5-Mar-03 | Seropositive 13 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900047255011117DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 12 Y | Female | Non-Hispanic | <-70C | 11-Jan-17 | Abbott M2000 RT-PCR | 998 copies/mL | 11-Jan-17 | Most Recent CD4 Results | 907 cells/?L | 30-Nov-16 | 10-Dec-06 | Seropositive 12 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053116011817DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 12 Y | Female | Non-Hispanic | <-70C | 18-Jan-17 | Abbott M2000 RT-PCR | 1000 copies/mL | 18-Jan-17 | Most Recent CD4 Results | 520 cells/?L | 30-Nov-16 | 14-Nov-05 | Seropositive 12 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053117110216DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 31 Y | Male | Non-Hispanic | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 721 cells/uL | 1-Sep-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053118112316DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 12 Y | Male | Non-Hispanic | <-70C | 23-Nov-16 | Abbott M2000 RT-PCR | 1002 copies/mL | 23-Nov-16 | Most Recent CD4 Results | 1019 cells/?L | 8-Nov-16 | 20-Jul-07 | Seropositive 12 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053119110216DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 42 Y | Male | Non-Hispanic | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 412 cells/uL | 15-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053120102716DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 32 Y | Female | Non-Hispanic | <-70C | 27-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 950 cells/uL | 11-Jul-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053122102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 30 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 808 cells/uL | 22-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053123021517DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 12 Y | Male | Non-Hispanic | <-70C | 15-Feb-17 | Abbott M2000 RT-PCR | 1002 copies/mL | 15-Feb-17 | Most Recent CD4 Results | 938 cells/?L | 15-Sep-16 | 10-Dec-05 | Seropositive 12 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053131110216DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 39 Y | Female | Non-Hispanic | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 721 cells/uL | 30-Aug-16 | $250.00 | Unknown | Yes | AZT; 3TC; ABC | None | No | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053132102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 26 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 370 cells/uL | 22-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900053133102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 40 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 692 cells/uL | 1-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061912102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 26 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 207 cells/uL | 28-Jul-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061913102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 36 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 565 cells/uL | 27-Jul-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061915102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 29 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 333 cells/uL | 23-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061916102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 29 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 508 cells/uL | 26-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061917102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 45 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 203 cells/uL | 15-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061919102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 43 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 370 cells/uL | 1-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061921102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 37 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 879 cells/uL | 28-Jul-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900061923102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 40 Y | Female | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 998 cells/uL | 16-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111007110216DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 25 Y | Female | Non-Hispanic | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 370 cells/uL | 24-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111008102616DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 19 Y | Male | Non-Hispanic | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 412 cells/uL | 23-Aug-16 | $250.00 | Unknown | HIV Seropositive | Sexual transmission | ||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111874021517DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 10 Y | Male | Non-Hispanic | <-70C | 15-Feb-17 | Abbott M2000 RT-PCR | 1001 copies/mL | 15-Feb-17 | Most Recent CD4 Results | 964 cells/?L | 30-Nov-16 | 5-Jan-07 | Seropositive 10 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111874113016DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 11 Y | Male | Non-Hispanic | <-70C | 30-Nov-16 | Abbott M2000 RT-PCR | 869 copies/mL | 30-Nov-16 | Most Recent CD4 Results | 907 cells/?L | 2-Sep-16 | 11-Apr-08 | Seropositive 11 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111874120716DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 12 Y | Male | Non-Hispanic | <-70C | 07-Dec-16 | Abbott M2000 RT-PCR | 768 copies/mL | 7-Dec-16 | Most Recent CD4 Results | 900 cells/?L | 30-Sep-16 | 19-Mar-06 | Seropositive 12 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AB900111874122116DD | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 11 Y | Male | Non-Hispanic | <-70C | 21-Dec-16 | Abbott M2000 RT-PCR | 1001 copies/mL | 21-Dec-16 | Most Recent CD4 Results | 520 cells/?L | 29-Nov-16 | 3-Jan-06 | Seropositive 11 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037229111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 49 Y | Male | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 1 year | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037234111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 24 Y | Female | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 4 years | Yes | Atazanavir; Ritonavir; Truvada | None | No | Mutations: K103N, K101E | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037235111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 21 Y | Male | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 15 days | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037236111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 43 Y | Female | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | AIDS | Diagnostic Status | AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 9 years | Yes | Lopinavir; Ritonavir; Zidovuvine; Abacavir; Lamivudine | Meningitis, Criptococcus | Meningitis, Criptococcus | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037237111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 45 Y | Male | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 22 years | Yes | Atazanavir; Kivexa; Norvir | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037238111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 45 Y | Female | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 1 year | Yes | Atripla | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037239111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 40 Y | Female | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 3 years | Yes | Atripla | Syphilis | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900037240111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 31 Y | Female | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 4 years | Yes | Kaletra; Kivexa | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900041916111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 38 Y | Male | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 3 years | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900041917111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 24 Y | Male | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Unknown | $250.00 | Unknown | Seropositive 1 month | No | None | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900043904111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 27 Y | Female | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 1 year | Yes | Atripla | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900043905111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 50 Y | Male | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | AIDS | Diagnostic Status | AIDS | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 5 years | Yes | Atazanavir; Ritonavir; Truvada | None | Herpes Zoster | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900043906111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 39 Y | Male | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 1 year | Yes | Kaletra; Combivir; Tipofovir; Previously: Atripla | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900066955111815DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 39 Y | Female | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 6 years | Yes | Atripla | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AC900066967111715DD | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 40 Y | Male | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $250.00 | Unknown | Seropositive 4 years | Yes | Atazanavir; Ritonavir; Truvada | None | No | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900066954080615DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $100.00 | 39 Y | Female | Unknown | <-70C | 06-Aug-15 | Roche cobas | 13,810 copies/mL | HIV | $100.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036416030617DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 19 Y | Male | Non-Hispanic | <-70C | 06-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 11-Nov-16 | Most Recent CD4 Results | 802 cells/uL | 22-Feb-17 | $250.00 | Unknown | Yes | Stribild | None | No | HIV Seropositive (1 year) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036417031017DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 59 Y | Female | Non-Hispanic | <-70C | 10-Mar-17 | Roche cobas RT-PCR | 30 copies/mL | 23-Nov-16 | Most Recent CD4 Results | 663 cells/uL | 10-Mar-17 | $250.00 | Unknown | Yes | Genvoya; Previously Stribild | None | No | HIV Seropositive (3 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036418032217DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 38 Y | Male | Non-Hispanic | <-70C | 22-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 3-Nov-16 | Most Recent CD4 Results | 1061 cells/uL | 22-Mar-17 | $250.00 | Unknown | Yes | Odefsey | Syphilis | No | HIV Seropositive (3 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036419032217DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 45 Y | Male | Non-Hispanic | <-70C | 22-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 16-Dec-16 | Most Recent CD4 Results | 784 cells/uL | 31-Mar-17 | $250.00 | Unknown | Yes | Kaletra Combivir | None | No | HIV Seropositive (8 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036425040717DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 48 Y | Male | Non-Hispanic | <-70C | 07-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 7-Apr-17 | Most Recent CD4 Results | 509 cells/uL | 7-Apr-17 | $250.00 | Unknown | Yes | Genvoya | None | No | HIV Seropositive (10 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036426032917DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 65 Y | Male | Non-Hispanic | <-70C | 29-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 5-Aug-16 | Most Recent CD4 Results | 1111 cells/uL | 29-Mar-17 | $250.00 | Unknown | Yes | Sustiva Epzicom | None | No | HIV Seropositive (14 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900036429041217DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 55 Y | Male | Non-Hispanic | <-70C | 12-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 12-Apr-17 | Most Recent CD4 Results | 324 cells/uL | 12-Apr-17 | $250.00 | Unknown | Yes | Atripla | None | No | HIV Seropositive (6 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900043411032117DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 52 Y | Male | Non-Hispanic | <-70C | 21-Mar-17 | Roche cobas RT-PCR | 36,880 copies/mL | 8-Jul-16 | Most Recent CD4 Results | 75 cells/uL | 8-Jul-16 | $250.00 | Unknown | Yes | Triumeq | None | No | AIDS / HIV Seropositive 12 years | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900043412092417DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 5.00 | $250.00 | 55 Y | Male | Non-Hispanic | <-70C | 24-Sep-17 | Roche cobas RT-PCR | <20 copies/mL | 28-Feb-17 | Most Recent CD4 Results | 406 cells/uL | 24-Feb-17 | $250.00 | Unknown | Yes | Genvoya; Previously Stribild | None | No | HIV Seropositive (2 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900049926032117DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 47 Y | Female | Non-Hispanic | <-70C | 21-Mar-17 | Roche cobas RT-PCR | 30 copies/mL | 17-Nov-16 | Most Recent CD4 Results | 444 cells/uL | 21-Mar-17 | $250.00 | Unknown | Yes | Genvoya; Previously Atripla | None | No | HIV Seropositive (10 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900049927030717DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 62 Y | Male | Non-Hispanic | <-70C | 07-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 16-Sep-16 | Most Recent CD4 Results | 720 cells/uL | 7-Mar-17 | $250.00 | Unknown | Yes | Genvoya; Previously Stribild | None | No | HIV Seropositive (21 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900049928032317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 27 Y | Male | Non-Hispanic | <-70C | 23-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 18-Sep-16 | Most Recent CD4 Results | 656 cells/uL | 23-Mar-17 | $250.00 | Unknown | Yes | Odefsey; Previously Complera | None | No | HIV Seropositive (5 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900049929052317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 59 Y | Female | Non-Hispanic | <-70C | 23-May-17 | Roche cobas RT-PCR | <20 copies/mL | 23-May-17 | Most Recent CD4 Results | 437 cells/uL | 23-May-17 | $250.00 | Unknown | Yes | Genvoya | Hepatitis C | No | AIDS / HIV Seropositive (28 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900049933032817DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 26 Y | Male | Non-Hispanic | <-70C | 28-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 23-Nov-16 | Most Recent CD4 Results | 568 cells/uL | 28-Mar-17 | $250.00 | Unknown | Yes | Genvoya | None | No | HIV Seropositive (7 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900063777100316DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 36 Y | Male | Non-Hispanic | <-70C | 03-Oct-16 | Roche cobas RT-PCR | 11,010 copies/mL | 30-Sep-16 | Most Recent CD4 Results | 275 cells/uL | 30-Sep-16 | HIV Genotype Testing | N/A | N/A | $250.00 | Unknown | Yes | Atripla | None | No | HIV Seropositive (3 years) | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900063778010917DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 43 Y | Male | Non-Hispanic | <-70C | 09-Jan-17 | Roche cobas RT-PCR | 5,520 copies/mL | 9-Jan-17 | Most Recent CD4 Results | 576 cells/uL | 9-Jan-17 | HIV Genotype Testing | N/A | N/A | $250.00 | Unknown | No | Genvoya Previously Atripla | None | No | HIV Seropositive (19 years) | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900063779081516DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 37 Y | Female | Non-Hispanic | <-70C | 15-Aug-16 | Roche cobas RT-PCR | 230 copies/mL | 12-Aug-16 | Most Recent CD4 Results | 547 cells/uL | 12-Aug-16 | HIV Genotype Testing | N/A | N/A | $250.00 | Unknown | Yes | Odefsey | None | No | HIV Seropositive (1 year) | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900063780012317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 36 Y | Male | Hispanic | <-70C | 23-Jan-17 | Roche cobas RT-PCR | 130 copies/mL | 21-Jan-17 | Most Recent CD4 Results | 492 cells/uL | 21-Jan-17 | HIV Genotype Testing | N/A | N/A | $250.00 | Unknown | Yes | Stribild | None | No | HIV Seropositive (4 years) | IV Drug Abuse | |||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900063781022217DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 55 Y | Male | Non-Hispanic | <-70C | 22-Feb-17 | Roche cobas RT-PCR | 18,610 copies/mL | 21-Feb-17 | Most Recent CD4 Results | 488 cells/uL | 21-Feb-17 | $250.00 | Unknown | No | None currently or previously | Syphilis | No | HIV Seropositive | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900063782020617DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 46 Y | Male | Non-Hispanic | <-70C | 06-Feb-17 | Roche cobas RT-PCR | 2,140 copies/mL | 3-Feb-17 | Most Recent CD4 Results | 2090 cells/uL | 3-Feb-17 | $250.00 | Unknown | Yes | Isentress Truvada | None | No | HIV Seropositive (16 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900067815011317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 52 Y | Female | Non-Hispanic | <-70C | 13-Jan-17 | Roche cobas RT-PCR | 150 copies/mL | 13-Jan-17 | Most Recent CD4 Results | 385 cells/uL | 13-Jan-17 | HIV Genotype Testing | N/A | N/A | $250.00 | Unknown | Yes | Complera | None | No | HIV Seropositive (19 years) | IV Drug Abuse | |||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900067816021717DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 27 Y | Male | Non-Hispanic | <-70C | 17-Feb-17 | Roche cobas RT-PCR | 630 copies/mL | 17-Feb-17 | Most Recent CD4 Results | 1311 cells/uL | 17-Feb-17 | $250.00 | Unknown | Yes | Complera | None | No | HIV Seropositive (3 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900067817081516DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 35 Y | Male | Non-Hispanic | <-70C | 15-Aug-16 | Roche cobas RT-PCR | 7,570 copies/mL | 13-Aug-16 | Most Recent CD4 Results | 521 cells/uL | 13-Aug-16 | HIV Genotype Testing | N/A | N/A | $250.00 | Unknown | Yes | Complera | None | No | HIV Seropositive (7 years) | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900075631050917DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 22 Y | Male | Non-Hispanic | <-70C | 09-May-17 | Roche cobas RT-PCR | <20 copies/mL | 9-May-17 | Most Recent CD4 Results | 578 cells/uL | 9-May-17 | $250.00 | Unknown | Yes | Odefsey | Gonorrhea | No | HIV Seropositive (1 year) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900075633030617DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 8.00 | $250.00 | 69 Y | Female | Non-Hispanic | <-70C | 06-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 17-Nov-16 | Most Recent CD4 Results | 75 cells/uL | 6-Mar-17 | $250.00 | Unknown | Yes | Intelence Prezista Isentress Norvir | None | No | AIDS / HIV Seropositive (22 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900075635030317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 33 Y | Female | Non-Hispanic | <-70C | 03-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 4-Nov-16 | Most Recent CD4 Results | 582 cells/uL | 3-Mar-17 | $250.00 | Unknown | Yes | Truvada Viramune | None | No | HIV Seropositive (12 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900075636032317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 64 Y | Male | Non-Hispanic | <-70C | 23-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 21-Nov-16 | Most Recent CD4 Results | 418 cells/uL | 23-Mar-17 | $250.00 | Unknown | Yes | Reyataz Norvir Isentress | None | No | HIV Seropositive (19 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900075638022317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 24 Y | Male | Non-Hispanic | <-70C | 23-Feb-17 | Roche cobas RT-PCR | <20 copies/mL | 8-Dec-16 | Most Recent CD4 Results | 416 cells/uL | 23-Feb-17 | $250.00 | Unknown | Yes | Tivicay Epzicom | None | No | HIV Seropositive (1 year) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900075639030617DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 64 Y | Male | Non-Hispanic | <-70C | 06-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 4-Aug-16 | Most Recent CD4 Results | 632 cells/uL | 6-Mar-17 | $250.00 | Unknown | Yes | Descovy Prezista Isentress Norvir | None | No | HIV Seropositive (21 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900079972050417DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 29 Y | Male | Non-Hispanic | <-70C | 04-May-17 | Roche cobas RT-PCR | <20 copies/mL | 4-May-17 | Most Recent CD4 Results | 439 cells/uL | 4-May-17 | $250.00 | Unknown | Yes | Reyataz Norvir Truvada | Hepatitis B | No | HIV Seropositive (3 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900079973051517DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 5.00 | $250.00 | 42 Y | Male | Non-Hispanic | <-70C | 15-May-17 | Roche cobas RT-PCR | <20 copies/mL | 15-May-17 | Most Recent CD4 Results | 722 cells/uL | 15-May-17 | $250.00 | Unknown | Yes | Genvoya | None | No | HIV Seropositive (15 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900079974041117DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 10.00 | $250.00 | 54 Y | Female | Non-Hispanic | <-70C | 11-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 1-Sep-16 | Most Recent CD4 Results | 1974 cells/uL | 1-Sep-16 | $250.00 | Unknown | Yes | Triumeq | None | No | HIV Seropositive (9 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900079975041117DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 5.00 | $250.00 | 55 Y | Female | Non-Hispanic | <-70C | 11-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 11-Apr-17 | Most Recent CD4 Results | 561 cells/uL | 11-Apr-17 | $250.00 | Unknown | Yes | Reyataz Combivir | None | No | HIV Seropositive (23 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900079976031717DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 40 Y | Male | Non-Hispanic | <-70C | 17-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 12-Dec-16 | Most Recent CD4 Results | 630 cells/uL | 9-Mar-17 | $250.00 | Unknown | Yes | Triumeq | None | No | HIV Seropositive (2 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900079978041117DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 27 Y | Male | Non-Hispanic | <-70C | 11-Apr-17 | Roche cobas RT-PCR | 2,724 copies/mL | 11-Apr-17 | Most Recent CD4 Results | 358 cells/uL | 11-Apr-17 | HIV Genotype Testing | N/A | N/A | $250.00 | Unknown | Yes | Stribild | None | No | HIV Seropositive (5 years) | Sexual Transmission | |||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900079979050317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 54 Y | Male | Non-Hispanic | <-70C | 03-May-17 | Roche cobas RT-PCR | <20 copies/mL | 3-May-17 | Most Recent CD4 Results | 1153 cells/uL | 3-May-17 | $250.00 | Unknown | Yes | Isentress Intelence | None | No | HIV Seropositive (17 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900079980040617DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 22 Y | Male | Non-Hispanic | <-70C | 06-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 6-Apr-17 | Most Recent CD4 Results | 841 cells/uL | 6-Apr-17 | $250.00 | Unknown | Yes | Odefsey | Syphilis | No | HIV Seropositive (2 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900079981022317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 47 Y | Male | Non-Hispanic | <-70C | 23-Feb-17 | Roche cobas RT-PCR | <20 copies/mL | 25-Feb-17 | Most Recent CD4 Results | 983 cells/uL | 23-Feb-17 | $250.00 | Unknown | Yes | Genvoya | None | No | HIV Seropositive (23 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900084943032117DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 47 Y | Male | Non-Hispanic | <-70C | 21-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 14-Nov-16 | Most Recent CD4 Results | 508 cells/uL | 8-Mar-17 | $250.00 | Unknown | Yes | Odefsey | None | No | HIV Seropositive (8 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900084944041717DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 6.00 | $250.00 | 57 Y | Male | Non-Hispanic | <-70C | 17-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 17-Apr-17 | Most Recent CD4 Results | 499 cells/uL | 17-Apr-17 | $250.00 | Unknown | Yes | Triumeq | None | No | HIV Seropositive (9 years) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BD900084946030817DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 56 Y | Female | Non-Hispanic | <-70C | 08-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 8-Oct-16 | Most Recent CD4 Results | 1873 cells/uL | 8-Mar-17 | $250.00 | Unknown | Yes | Odefsey | None | No | HIV Seropositive (<1 year) | Sexual Transmission | ||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BW900046637032111DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 54 Y | Male | Unknown | < -70C | 21-Mar-11 | Roche Amplicor | U/A | HIV | CD4 Result | 495 K/uL | $250.00 | Unknown | Currently taking ART; Drugs: Zerit, Ziagen, Viracept | Hepatitis C, history of neurosyphilis | IV Drug Abuse | History of proteinuria & hypercholesterol, cataract surgery to right eye, HTN, uveitis, glaucoma, G6PD deficient, recurrent abcesses on face & neck | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BW900046638030311DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 6.00 | $250.00 | 48 Y | Male | Unknown | < -70C | 03-Mar-11 | Roche Amplicor | 37 copies/mL | HIV | CD4 Result | 398 K/uL | $250.00 | Unknown | Currently taking ART; Drugs: Lexiva, Norvir, Isentress, Zerit, Epivir | Hepatitis C | Sexual Transmission | PML - current, CAP - 2/2011, past DVT & PE (recurrent) | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BW900046643031711DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 54 Y | Male | Unknown | < -70C | 17-Mar-11 | Roche Amplicor | 228 copies/mL | HIV | CD4 Result | 978 K/uL | $250.00 | Unknown | Currently taking ART; Drugs: Atripla | No co-infections | Sexual Transmission | Hyperlipidemia, alcohol abuse, increased liver enzymes, gout | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BW900046645030211DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 62 Y | Male | Unknown | < -70C | 02-Mar-11 | Roche Amplicor | 138 copies/mL | HIV | CD4 Result | 905 K/uL | $250.00 | Unknown | Currently taking ART; Drugs: Atripla Slight hemolysis on one tube | Hepatitis A + 1/8/10 | Transfusion | No Symptoms | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-BW900046646032111DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 53 Y | Male | Unknown | < -70C | 21-Mar-11 | Roche Amplicor | 59 copies/mL | HIV | CD4 Result | 141 K/uL | $250.00 | Unknown | Currently taking ART; Drugs: Emtriva, Norvir, Prezista, Isentress, Intelence | Hx of syphilis | Sexual Transmission | Hx of lymphoma, prostatitis, osteopenia, extrasystole, mild renal insufficiency, syphilis, PCP - 10/2003, hyperlipidemia, low Vitamin D | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900045245021517DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 50 Y | Female | Non-Hispanic | <-70C | 15-Feb-17 | Roche cobas RT-PCR | <20 copies/mL | 7-Feb-17 | Most Recent CD4 Results | N/A | N/A | $250.00 | Unknown | Yes | Tivicay Complera | None | Decreased appetite; Abdominal pain; Joint pain; Night sweats; Depression; Unexplained weight loss | HIV Seropositive (27 years) | Sexual Transmission | ALT: 32 IU/L; AST: 35 IU/L; Bilirubin: 0.4 mg/dL; Serum Creatinine: 0.86 mg/dL; 7-Feb-17 | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900045246022017DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 56 Y | Female | Non-Hispanic | <-70C | 20-Feb-17 | Roche cobas RT-PCR | 26 copies/mL | 13-Feb-17 | Most Recent CD4 Results | 416 cells/uL | 13-Feb-17 | $250.00 | Unknown | Yes | Genvoya | None | Depression | HIV Seropositive (24 years) | Transfusion | None | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900051107022017DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 55 Y | Female | Non-Hispanic | <-70C | 20-Feb-17 | Roche cobas RT-PCR | Not detected | 10-Feb-17 | Most Recent CD4 Results | 1;154 cells/uL | 10-Feb-17 | $250.00 | Unknown | Yes | Tivicay Intelence | None | Night sweats; Yeast infections in mouth; throat or vagina | HIV Seropositive (7 years) | Sexual Transmission | ALT: 40 IU/L; AST: 36 IU/L; ALP: 93 IU/L; Bilirubin: 0.5 mg/dL; Serum Creatinine: 0.86 mg/dL; 10-Feb-17 | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900051108022317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 25 Y | Male | Non-Hispanic | <-70C | 23-Feb-17 | Roche cobas RT-PCR | <20 copies/mL | 14-Feb-17 | Most Recent CD4 Results | 773 cells/uL | 14-Feb-17 | $250.00 | Unknown | Yes | Odefsey;; Previously took Complera | None | None | HIV Seropositive (4 years) | Sexual Transmission | ALT: 14 IU/L; AST: 16 IU/L:Bilirubin: 0.7 mg/dL; 14-Feb-17 | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900051109022317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 56 Y | Female | Non-Hispanic | <-70C | 23-Feb-17 | Roche cobas RT-PCR | Not detected | 13-Feb-17 | Most Recent CD4 Results | 710 cells/uL | 13-Feb-17 | $250.00 | Unknown | Yes | Genvoya; Previously took Stribild; Atripla | None | None | HIV Seropositive ( 29 years) | Sexual Transmission | None | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900051111010617DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $250.00 | 54 Y | Male | Non-Hispanic | <-70C | 06-Jan-17 | Roche cobas RT-PCR | <20 copies/mL | 27-Dec-16 | Most Recent CD4 Results | 175 cells/uL | 27-Dec-16 | $250.00 | Unknown | Yes | Descovy Prezcobix | None | None | HIV Seropositive (13 years) | Sexual Transmission | ALT: 24 IU/L; AST: 29 IU/L; ALP: 96 IU/L; Bilirubin: 0.4 mg/dL; Serum Creatinine: 1.20 mg/dL; 27-Dec-16 | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900051113011717DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 61 Y | Female | Non-Hispanic | <-70C | 17-Jan-17 | Roche cobas RT-PCR | Not detected | 10-Jan-17 | Most Recent CD4 Results | 919 cells/uL | 10-Jan-17 | $250.00 | Unknown | No | None | None | None | HIV Seropositive (18 years) | Sexual Transmission | None | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900051114012617DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 25 Y | Female | Non-Hispanic | <-70C | 26-Jan-17 | Roche cobas RT-PCR | <20 copies/mL | 20-Jan-17 | Most Recent CD4 Results | 565 cells/uL | 20-Jan-17 | $250.00 | Unknown | Yes | Odefsey | None | None | HIV Seropositive (5 years) | Sexual Transmission | ALT: 15 IU/L; AST: 17 IU/L; ALP: 63 IU/L; Bilirubin: 0.4 mg/dL; Serum Creatinine: 0.82 mg/dL; 20-Jan-17 | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-FI900058896010317DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 3.00 | $250.00 | 48 Y | Female | Non-Hispanic | <-70C | 03-Jan-17 | Roche cobas RT-PCR | Not detected | 27-Dec-16 | Most Recent CD4 Results | 626 cells/uL | 27-Dec-16 | $250.00 | Unknown | Yes | Genvoya Prezista | None | None | HIV Seropositive (21 years) | Sexual Transmission | None | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-K7900023396020415DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 1.00 | $250.00 | 55 Y | Female | Non-Hispanic | <-70C | 04-Feb-15 | CD4 Result | 1,378 cells/uL | 3-Feb-15 | Most Recent Viral Load | 63 copies/mL | 3-Feb-15 | None | $250.00 | Unknown | Yes | Atzanavir Ritonavir Truvada Zidovudine | N/A | Heterosexual sex | 14-Jul-00 | 4.1 g/dL | 298 U/L | 20 U/L | 22 U/L 3-Feb-15 | 1.3 mg/dL | <0.1 mg/dL | 33 U/L | ||||||||||||||||||||||||||||||||||||||||
| EDP0000-K7900023398121410DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 1.00 | $250.00 | 40 Y | Male | Non-Hispanic | <-70C | 14-Dec-10 | CD4 Result | 622 cells/uL | 23-Dec-10 | Most Recent Viral Load | 277 copies/mL | 23-Dec-10 | None | $250.00 | Unknown | Yes | Kaletra Truvada | HCV | Male sex with male and injected drug use | 7-Dec-98 | 3.8 g/dL | 68 U/L | 41 U/L | 32 U/L 23-Dec-10 | 0.6 mg/dL | 0.1 mg/dL | | ||||||||||||||||||||||||||||||||||||||||
| EDP0000-K7900023399081909DD | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 1.00 | $250.00 | 41 Y | Female | Non-Hispanic | <-70C | 19-Aug-09 | CD4 Result | 157 cells/uL | 8-Jul-09 | Most Recent Viral Load | 287 copies/mL | 8-Jul-09 | None | $250.00 | Unknown | Yes | Abacavir Atazanavir Ritonavir Truvada | N/A | Heterosexual sex | 30-May-97 | 3.3 g/dL | 94 U/L | 19 U/L | 18 U/L 8-Jul-09 | 2.8 mg/dL | 0.5 mg/dL | 199 U/L | ||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900345994101519DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 15-Oct-19 | Abbott VL | Abbott HIV-1 | PCR | 3,923 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900345995101719DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 1.00 | $100.00 | Y | Female | Non-Hispanic | <-70C | 17-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 868,000 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900345996101719DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 17-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 275 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900346203101119DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 2.00 | $100.00 | Y | Female | Non-Hispanic | <-70C | 11-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 1,090 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900346869101719DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 2.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 17-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 220 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900347224100919DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 1.00 | $100.00 | Y | Female | Non-Hispanic | <-70C | 09-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 103,000 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900347225100919DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 09-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 190,000 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900347226100919DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 09-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 758,000 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900355294100319DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 03-Oct-19 | Roche VL | Cobas HIV-1 | PCR | 11,600 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K2E0000-G2900355387101019DD | Human immunodeficiency virus (HIV) | K3 EDTA | 1.10 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 10-Oct-19 | Abbott VL | Abbott HIV-1 | PCR | 33,775 | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| KDT1000-AB900111874120716DD | Human immunodeficiency virus (HIV) | Uganda | 1 K2 EDTA Plasma | 1.00 | 4.00 | $250.00 | 13 Y | Male | Non-Hispanic | <-70C | 07-Dec-16 | Abbott M2000 RT-PCR | 1001 copies/mL | 7-Dec-16 | Most Recent CD4 Results | 998 cells/?L | 11-Oct-16 | 20-Feb-04 | Seropositive 13 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| KDT1000-AB900111874122116DD | Human immunodeficiency virus (HIV) | Uganda | 1 K2 EDTA Plasma | 1.00 | 2.00 | $250.00 | 11 Y | Male | Non-Hispanic | <-70C | 21-Dec-16 | Abbott M2000 RT-PCR | 1009 copies/mL | 21-Dec-16 | Most Recent CD4 Results | 509 cells/?L | 21-Dec-16 | 18-May-07 | Seropositive 11 years | $250.00 | Unknown | Yes | 3TC ; TDF; EFV | Transplacental | No | ||||||||||||||||||||||||||||||||||||||||||
| LHP0000-AI900355223052219DD | Human immunodeficiency virus (HIV) | L. Heparin Plasma | 1.10 | 1.00 | $100.00 | Y | Male | Non-Hispanic | <-70C | 22-May-19 | Abbott Architect | Positive | HIV | $100.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| RUI0000-AI900108378081318DD | Human immunodeficiency virus (HIV) | USA | 3.50 | 1.00 | $75.00 | 50 Y | Female | <-70C | 13-Aug-18 | Abbott Architect | Positive | HIV | $75.00 | Unknown |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.